Agreement Extension NoticeExclusive Call Option Agreement • August 10th, 2018 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Contract Type FiledAugust 10th, 2018 Company IndustryWhereas iKang Health Technology Group Co., Ltd. (formerly known as Shanghai Guobin Medical Holding Co., Ltd., hereinafter referred to as “iKang Technology”), Mr. Boquan He, Mr. Lee Ligang Zhang and iKang Healthcare Technology (Beijing) Co., Ltd. (hereinafter referred to as the “Company”) entered into the Exclusive Call Option Agreement (hereinafter referred to as the “Agreement”) on March 17, 2008. The Agreement was valid from March 17, 2008 to March 16, 2018.
Supplemental Agreement II to the Loan AgreementLoan Agreement • August 10th, 2018 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Contract Type FiledAugust 10th, 2018 Company IndustryThis Supplemental Agreement II to the Loan Agreement (hereinafter referred to as the “Supplemental Agreement II”) is entered into by the following Parties in accordance with relevant Chinese laws, regulations and rules on July 10, 2017 in the People’s Republic of China (hereinafter referred to as “China”):
Supplemental Agreement to the Investment AgreementSupplemental Agreement to the Investment Agreement • August 10th, 2018 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Contract Type FiledAugust 10th, 2018 Company IndustryThis Supplemental Agreement to the Investment Agreement (the “Supplemental Agreement”) was entered into by the following parties in accordance with relevant Chinese laws, regulations and rules on December 13, 2017:
Supplemental Agreement III to the Loan AgreementLoan Agreement • August 10th, 2018 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Contract Type FiledAugust 10th, 2018 Company IndustryThis Supplemental Agreement III to the Loan Agreement (hereinafter referred to as the “Agreement”) is entered into by the following Parties on March 23, 2018 in Beijing, China:
Limited Partnership) Agreement of Hangkang Investment Management Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area AVICTC2017X0652-1 December 2017Limited Partnership Agreement • August 10th, 2018 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine • Macau
Contract Type FiledAugust 10th, 2018 Company Industry JurisdictionAnnex II: Notice of Contributions for Phase i of Ningbo Meishan Bonded Port Area Hangkang Investment Management Partnership (Limited Partnership) (Template) 44
Forward Share Purchase Agreement Contract No.: AVICTC2017X0652-3Forward Share Purchase Agreement • August 10th, 2018 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Contract Type FiledAugust 10th, 2018 Company IndustryIn accordance with the Company Law of the People’s Republic of China, the Contract Law of the People’s Republic of China, the Partnership Law of the People’s Republic of China, and other applicable laws and administrative regulations, the Parties, in the principles of good faith, fairness and free will and through amicable consultation, hereby enter into this Agreement on the purchase matters for mutual abidance.
No.: [XYZG[2017]-H20170009-HHXY] Limited Partnership Agreement of Aiying Xingsheng Medical Equity Investment Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area Executed in [Pudong New Area, Shanghai] [October] 2017Limited Partnership Agreement • August 10th, 2018 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Contract Type FiledAugust 10th, 2018 Company IndustryThis Agreement is entered into by and among the general partner Yuansheng Investment Management Co., Ltd. of Ningbo Meishan Bonded Port Area (“Ningbo Yuansheng”), the general partner Ligang Capital Investment (Shenzhen) Co., Ltd. (“Ligang Capital”), the senior limited partner China Industrial Asset Management Limited (on behalf of China Industrial — iKang Medical Contractual Private Investment Fund I) (“China Industrial”), the junior limited partner Shanghai Yuansheng Investment Management Co., Ltd. (“Shanghai Yuansheng”), and the junior limited partner iKang Health Technology Group Co., Ltd. (“iKang Health Technology”) on [the twentieth day of October 2017] in [Pudong New Area, Shanghai].